Fri, July 25, 2014
Thu, July 24, 2014
Wed, July 23, 2014
Tue, July 22, 2014
Mon, July 21, 2014

Christopher Marai Maintained (BIIB) at Strong Buy with Increased Target to $424 on, Jul 24th, 2014

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-424-on-jul-24th-2014.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Christopher Marai of Nomura, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $415 to $424 on, Jul 24th, 2014.

Christopher has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Cory Kasimov of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $375 on, Thursday, May 29th, 2014
  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014